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Abstract
Background: Leiomyosarcoma is a rare malignant mesenchymal tumor that represents 5–7 % of all soft tissue
sarcomas. The occurrence of this tumor in the salivary glands is exceptional. Only five cases are reported in the
submandibular gland.
Case presentation: A 65-year-old white Moroccan woman presented with a history of progressive right submandibular
swelling which had grown over a period of 8 months. Clinical examination showed a submandibular painless, mobile and
hard mass without cervical lymphadenopathy. Ultrasonography and computed tomography revealed a solid and
heterogeneous mass measuring 4 × 2 cm involving the submandibular gland. A resection of the gland was performed.
Pathological findings were consistent with primary leiomyosarcoma of the submandibular gland. No recurrence occurred
after two months of follow-up.
Conclusion: Primary leiomyosarcoma of the submandibular gland is an extremely rare mesenchymal tumor. Clinical and
radiological features are not specific. Differential diagnosis includes metastatic leiomyosarcoma and gastrointestinal
stromal tumor, myoepithelioma, sarcomatoid carcinoma, melanoma and other sarcomas. Little is known about the
overall biologic behavior of this tumor, but the prognosis seems to be poor.
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Background
Primary sarcomas of the salivary glands are rare ac-
counting for 0,3–1,5 % of salivary gland neoplasms and
1,5–2,3 % of malignant salivary tumors [1]. They arise
mainly in the parotid gland and only in 10 % of cases in
the submandibular gland [2].
Leiomyosarcoma is a malignant mesenchymal tumor
with smooth muscles origin that represents 5–7 % of all
soft tissue sarcomas [3]. The occurrence of this tumor in
the salivary glands is exceptional [2, 4].
Five cases of primary leiomyosarcoma of the sub-




A 65 year-old white woman, without clinical antecedents,
presented with a history of progressive right submandibular
swelling which had grown over a period of 8 months.
Clinical examination showed a submandibular painless,
mobile and hard mass measuring 4 × 2 cm without cervical
lymphadenopathy.
Radiologic and histopathologic findings
Ultrasonography and computed tomography revealed a
solid and heterogeneous mass measuring 4 x 2 cm in-
volving the right submandibular gland. There was no
cervical lymphadenopathy. A resection of the right sub-
mandibular gland was performed.
Macroscopically, the specimen measured 6 x 4 x 2 cm.
The tumor appeared as a grey white, hard mass and 4 × 2
cm in dimension. Histological examination showed inter-
secting fascicles of spindle cells (Fig. 1) with ample
amount of eosinophilic cytoplasm and elongated nuclei
with dispersed chromatin. The cells presented high mi-
totic activity (5 per 10 high-power fields) and foci of
severe atypia without necrosis (Fig. 2). The adjacent
salivary parenchyma was infiltrated by tumoral cells
(Fig. 3). No areas of epithelial component were identi-
fied despite extensive sampling. Immunoreactivity with
anti smooth muscle actin and H-caldesmon (Fig. 4)
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antibodies was found. Desmin, S-100 protein, CD34,
CD31, CD117, and pancytokeratin were all negative.
Thus, a diagnosis of leiomyosarcoma of the subman-
dibular gland grade I FNCLCC (French Fédération
Nationale des Centres de Lutte Contre le Cancer) was
established. The post-operative course was uneventful.
The thoracoabdominal computed tomography, performed
subsequently, showed no distant tumor. The patient is
dowing well without any evidence of recurrences or
metastases after two months of follow-up.
Discussion
Primary sarcomas of the salivary glands are rare ac-
counting for 0,3–1,5 % of salivary gland neoplasms and
1,5–2,3 % of malignant salivary tumors [1]. Primary leio-
myosarcomas of the head and neck are uncommon
representing 3–10 % of leiomyosarcomas [5] and usually
occur between 40–50 years old [6]. They arise mainly in
the parotid gland and only 5 cases are reported in the
submandibular gland in patients aged above 60 years
[1, 2, 7, 8]. Tumors with the following criteria are con-
sidered primary salivary gland sarcoma: 1) The patient
must not have, or have had, a sarcoma elsewhere; 2) a
metastasis to the gland from malignancies of the skin
or mucosa of the upper aerodigestive tract must be ex-
cluded; 3) the gross and microscopic appearances
should be consistent with a primary origin, rather than
invasion from the adjacent soft tissues; and 4) within
Fig. 1 Salivary parenchyma harboring a well-circumscribed, fascicular
proliferation of spindle shaped cells (hematoxylin and eosin stain,
original magnification × 25)
Fig. 2 Tumor cells infiltrating the adjacent parenchyma (hematoxylin
and eosin stain, original magnification × 200)
Fig. 3 Tumor cells showing mild nuclear atypia with multinucleated
giant cells and mitosis (hematoxylin and eosin stain, original
magnification × 400)
Fig. 4 H-caldesmon positivity of the tumor cells (original
magnification × 400)
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the limits of the microscopic study of multiple sections,
carcinosarcoma has to be excluded [9].
Clinical features are not specific with a painless and
progressive mass being the most significant finding
[10–12]. Radiological investigations allow evaluation of
the extent of the tumor and assessment of the regional
lymph nodes [5, 13].
Microscopically, leiomyosarcoma shows a proliferation
of intersecting fascicles of spindle cells with ample
amount of eosinophilic cytoplasm and elongated nuclei
with dispersed chromatin [7]. Mitotic rate is superior to
2 mitosis per 10 high-power fields [5, 14]. Foci of pleo-
morphism and/or necrosis can be found [7]. Immuno-
histochemistry demonstrates positive staining of the
tumor cells for smooth muscle actin and H-caldesmon
[15]. Desmin can be either positive or negative [5, 14].
S-100 protein, CD34, CD31, CD117, and pancytokeratin
are generally negative [15]; these findings play an im-
portant role in excluding myoepithelioma, sarcomatoid
carcinoma, melanoma, metastatic gastrointestinal stromal
tumor, and other sarcomas [5, 7, 16]. However, the main
differential diagnosis is metastatic leiomyosarcoma from
other malignancies of head and neck sites, soft tissues and
uterine corpus; thus, clinical informations and imaging
studies are very important [7].
Staging of leiomyosarcoma of the head and neck in-
cludes chest and abdominal computed tomography and
bone scintigraphy [7].
The management is mainly surgical. Complete surgical
excision with clear margins is the mainstay of the treat-
ment [7, 12] being associated with low local recurrence
and longer survival [7]. Lymph node metastases are ex-
ceptional in sarcomas so that lymphadenectomy is not
indicated [7]. Adjuvant radiotherapy is recommended
for high grade sarcoma, large tumour, and close or posi-
tive surgical margins [2, 10, 12, 13]. Chemotherapy is
indicated for patients with inoperable tumors, local re-
currence or distant metastases [2].
The prognosis seems to related to the size (greater or
less than 3 cm), grade and site of the tumor and the
quality of surgery [7, 9]. For major salivary gland, the
prognosis is poor [2, 8].
In leiomyosarcoma of the head and neck, the five-year
survival is 23 % [2]. Recurrences are frequent and occur
in 40–60 % of cases [5]. Metastases are rare and occur
mainly in lung, bone and central nervous system [12].
Conclusion
In summary, primary leiomysarcoma of the mandibular
gland is a rare and aggressive mesenchymal tumor that
makes several problems in the differential diagnosis. An
accurate diagnosis is imperative because of its poor
prognosis. In our case, clinical informations and imaging
studies revealed no other tumors.
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